K2 Investment Partners

Point2 Technology, founded in 2016 and based in Seoul, South Korea, specializes in developing advanced connectivity solutions aimed at meeting the growing bandwidth demands of 5G and cloud-based data centers. The company focuses on creating dielectric waveguide technology that enables high-speed, short-range interconnectivity. Its products are designed to deliver reliable, low-cost, and low-power solutions, facilitating efficient point-to-point connections for data center applications. By addressing the critical needs of modern infrastructure, Point2 Technology positions itself as a key player in enhancing data connectivity for the future.

ImmuneOncia Therapeutics Inc., a biopharmaceutical company, develops anti-cancer drugs for the treatment of cancer. It develops IMC-001, an monoclonal antibody derived from a modified version to treat patients with various types of cancer. ImmuneOncia Therapeutics Inc. was incorporated in 2016 and is based in Yongin-Si, South Korea. ImmuneOncia Therapeutics Inc. is a joint venture between Yuhan Corporation and Sorrento Therapeutics.

Brandi is an online marketplace based in Seoul, South Korea, specializing in women's clothing and footwear. Founded in 2014, the company operates a fashion-based retail platform that connects manufacturers, wholesalers, and customers, facilitating a seamless shopping experience. Brandi aims to cater to young consumers by offering access to a variety of trending fashion brands at affordable prices. Through its innovative platform, the company fosters growth within the fashion ecosystem, empowering customers to make informed choices while enjoying a diverse selection of products.

Movv is a mobility service that makes movement more safe and convenient anytime and anywhere by using dedicated articles and vehicles. They offer dedicated drivers and cars to help travelers move safely and comfortably. With the mobile application, you can set up your travel itinerary and call your driver anytime anywhere, so you can enjoy your overseas travel with the movv.

Developer of three-dimensional (3D) robot vision technology designed to increase production efficiency in major industries. The company's technology recognizes and coordinates irregularly shaped products, creates optimal robot passes to increase the accuracy of the automotive processes, and automates essential manufacturing processes at a reasonable cost, enabling businesses to be precise and efficient.

Dable, Inc. is a South Korean company established in 2015 that operates an online content discovery platform utilizing big data. The company specializes in providing personalized content recommendation solutions and native advertising services, aiming to enhance user engagement through tailored product and content suggestions. By analyzing behavioral data from both online and offline interactions, Dable's platform enables businesses to create and edit content in real-time across various formats. This innovative approach not only helps clients increase page views and profitability but also seeks to enrich consumers' lifestyles by extending its personalization services beyond the digital realm. With a background in developing successful recommendation platforms, the team is focused on expanding its capabilities to meet the evolving needs of users and businesses alike.

Cupix, Inc. is a cloud-based software company established in 2015, based in Seongnam-si, South Korea. The company specializes in developing a photogrammetry solution that creates three-dimensional digital twins of physical spaces using 360-degree photos as input. Its software employs advanced computational geometry, computer vision, and machine learning technologies to generate realistic 3D representations of buildings, construction sites, and large facilities. Cupix offers functionalities such as dimension measurement, information annotations, interactive floor plans, and the ability to create, share, and manage virtual tours. The primary focus areas for the company are 3D documentation for construction sites and virtual tour authoring for real estate, enabling users to access and manage physical spaces virtually at any time.

ExoCoBio Inc. is a South Korean company founded in 2017 that specializes in the development of biopharmaceuticals and cosmeceuticals utilizing stem cell-derived exosomes. These nano-vesicles play a crucial role in intercellular signaling, which is essential for skin and tissue regeneration. The company focuses on creating innovative therapeutics and cosmetic products aimed at enhancing cellular tissue regeneration, thereby promoting overall health and well-being. ExoCoBio's research and development efforts are geared toward providing effective alternatives for clinicians and improving the quality of life through advanced regenerative medicine solutions.

Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Brandi is an online marketplace based in Seoul, South Korea, specializing in women's clothing and footwear. Founded in 2014, the company operates a fashion-based retail platform that connects manufacturers, wholesalers, and customers, facilitating a seamless shopping experience. Brandi aims to cater to young consumers by offering access to a variety of trending fashion brands at affordable prices. Through its innovative platform, the company fosters growth within the fashion ecosystem, empowering customers to make informed choices while enjoying a diverse selection of products.

Nunaps operates as a digital therapeutics startup.

ExoCoBio Inc. is a South Korean company founded in 2017 that specializes in the development of biopharmaceuticals and cosmeceuticals utilizing stem cell-derived exosomes. These nano-vesicles play a crucial role in intercellular signaling, which is essential for skin and tissue regeneration. The company focuses on creating innovative therapeutics and cosmetic products aimed at enhancing cellular tissue regeneration, thereby promoting overall health and well-being. ExoCoBio's research and development efforts are geared toward providing effective alternatives for clinicians and improving the quality of life through advanced regenerative medicine solutions.